Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Role of Neutrophils in Aspirin Treatment for Women at High Risk of Preeclampsia

NCT04974892 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT04974892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04974892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Role of Neutrophils in Aspirin Treatment for Women at High Risk of Preeclampsia
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Completed
Start date
April 27, 2022
Completion date
December 31, 2025
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunology, neutrophil, preeclampsia, pregnancy